Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2009
10/14/2009CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
10/14/2009CN100549009C Composition for detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone and method thereof
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100549006C Mitotic kinesin inhibitors
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548987C Pesticidal pyridinecarboxamide derivatives
10/14/2009CN100548980C Isoindoline derivative
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/13/2009US7601841 Quinolinyl and benzothiazolyl modulators
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601749 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601738 Excitatory amino acid receptor antagonists
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601721 Substituted heterocyclic compounds
10/13/2009CA2560510C N-(1-arylpyrazol-4yl) sulfonamides and their use as parasiticides
10/13/2009CA2419416C Tetrazolyl-phenyl acetamide glucokinase activators
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123855A1 3-indazolyl-4-pyridylisothiazoles
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009122968A1 Resin molded product and polymer film
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121535A2 Antiproliferative compounds and therapeutic uses thereof
10/08/2009WO2009121507A2 Substituted enaminothiocarbonyl compounds
10/08/2009WO2009099853A8 Angiotensin ii receptor antagonists
10/08/2009WO2009042435A8 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/08/2009WO2009019295A3 Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009US20090253906 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/08/2009US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/08/2009US20090253753 Therapeutic Use of Acylaminothiazole Derivatives
10/08/2009US20090253750 3-indazolyl-4-pyridylisothiazoles
10/08/2009US20090253749 Substituted enaminocarbonyl compounds
10/08/2009US20090253745 Modulators of ocular oxidative stress
10/08/2009US20090253727 Nociceptin analogs
10/08/2009US20090253705 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253671 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720275A1 Indolinone compound
10/08/2009CA2720176A1 Antiproliferative compounds and therapeutic uses thereof
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/07/2009EP2107058A1 Substituted enaminothiocarbonyl compounds
10/07/2009EP2107054A1 Antiproliferative compounds and therapeutic uses thereof
10/07/2009EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009EP1000043B1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
10/07/2009CN101553486A Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
10/07/2009CN101553471A 抗菌喹啉衍生物 Antibacterial quinoline derivatives
10/07/2009CN101553470A Antibacterial quinoline derivatives
10/07/2009CN101550135A Method for preparing AS-605240 and application thereof on preparing medicines for treating inflammatory diseases
10/07/2009CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009CN101550112A 4,5-disubstituted thiazole derivative, preparation method and use thereof
10/07/2009CN101550104A Benzene-naphthalene diimide derivative, preparation method and its application
10/07/2009CN100546580C Nicotin or isonicotin benzothiazole derivatives
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598392 1-(1,5-dimethyl-1H-pyrazole-3-carbonyl)piperidine-3-carboxylic acid [4-(5-cyclohexyl-2-methoxyphenyl)thiazol-2-yl]amide; chemokine receptor modulators
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598390 1-Benzyl-4-methyl-2-(1-methylimidazoyl)-quinolinium acetate, for example; compounds are stains that become fluorescent upon illumination and interaction with double stranded DNA, but exhibit reduced or no fluorescence in the absence of double stranded DNA
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598387 Synthesis of antidiabetic rosiglitazone derivatives
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598239 Side effect reduction; antiproliferative agents; schizophrenia
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2404121C Pyrimidine derivatives as hardness stabilizers
10/01/2009WO2009120826A1 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
10/01/2009WO2009120803A2 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator
10/01/2009WO2009119980A2 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
10/01/2009WO2009119880A1 Substituted pyrazole derivatives and use thereof
10/01/2009WO2009119776A1 Fused heterocyclic derivative and use thereof
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 628